- Home
- JZXN vs TLPH Comparison
JZXN vs TLPH Comparison
Compare JZXN & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JZXN
- TLPH
- Stock Information
- Founded
- JZXN 2019
- TLPH 2005
- Country
- JZXN China
- TLPH United States
- Employees
- JZXN N/A
- TLPH N/A
- Industry
- JZXN Retail-Auto Dealers and Gas Stations
- TLPH Biotechnology: Pharmaceutical Preparations
- Sector
- JZXN Consumer Discretionary
- TLPH Health Care
- Exchange
- JZXN Nasdaq
- TLPH Nasdaq
- Market Cap
- JZXN 10.3M
- TLPH 10.6M
- IPO Year
- JZXN 2021
- TLPH 2011
- Fundamental
- Price
- JZXN $1.11
- TLPH $0.42
- Analyst Decision
- JZXN
- TLPH Strong Buy
- Analyst Count
- JZXN 0
- TLPH 1
- Target Price
- JZXN N/A
- TLPH $6.00
- AVG Volume (30 Days)
- JZXN 77.2K
- TLPH 919.4K
- Earning Date
- JZXN 09-08-2025
- TLPH 08-13-2025
- Dividend Yield
- JZXN N/A
- TLPH N/A
- EPS Growth
- JZXN N/A
- TLPH N/A
- EPS
- JZXN N/A
- TLPH N/A
- Revenue
- JZXN $1,400,139.00
- TLPH $27,000.00
- Revenue This Year
- JZXN N/A
- TLPH N/A
- Revenue Next Year
- JZXN N/A
- TLPH $14,533.26
- P/E Ratio
- JZXN N/A
- TLPH N/A
- Revenue Growth
- JZXN N/A
- TLPH N/A
- 52 Week Low
- JZXN $0.84
- TLPH $0.38
- 52 Week High
- JZXN $7.82
- TLPH $1.19
- Technical
- Relative Strength Index (RSI)
- JZXN 40.41
- TLPH 42.40
- Support Level
- JZXN $0.97
- TLPH $0.38
- Resistance Level
- JZXN $1.29
- TLPH $0.79
- Average True Range (ATR)
- JZXN 0.11
- TLPH 0.06
- MACD
- JZXN 0.10
- TLPH -0.00
- Stochastic Oscillator
- JZXN 45.59
- TLPH 10.51
About JZXN Jiuzi Holdings Inc.
Jiuzi Holdings Inc operates as a franchise under the brand name Jiuzi. It sells new energy vehicles in third-fourth tier cities in China. The firm also sells plug-in electric vehicles on demand from vehicle buyers. Its operating segments are propretaey product; and resale of sourced Equipment and accessories from third party products. The company generates a majority of its revenue from the propretaey product segment. Geographically, the firm operates in China.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.